GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Kangji Medical Holdings Ltd (HKSE:09997) » Definitions » EV-to-Revenue

Kangji Medical Holdings (HKSE:09997) EV-to-Revenue : 6.34 (As of May. 15, 2024)


View and export this data going back to 2020. Start your Free Trial

What is Kangji Medical Holdings EV-to-Revenue?

EV-to-Revenue is calculated as enterprise value divided by its revenue. As of today, Kangji Medical Holdings's enterprise value is HK$6,422 Mil. Kangji Medical Holdings's Revenue for the trailing twelve months (TTM) ended in Dec. 2023 was HK$1,013 Mil. Therefore, Kangji Medical Holdings's EV-to-Revenue for today is 6.34.

The historical rank and industry rank for Kangji Medical Holdings's EV-to-Revenue or its related term are showing as below:

HKSE:09997' s EV-to-Revenue Range Over the Past 10 Years
Min: 3.51   Med: 8.38   Max: 75.18
Current: 6.32

During the past 7 years, the highest EV-to-Revenue of Kangji Medical Holdings was 75.18. The lowest was 3.51. And the median was 8.38.

HKSE:09997's EV-to-Revenue is ranked worse than
72.43% of 827 companies
in the Medical Devices & Instruments industry
Industry Median: 3.19 vs HKSE:09997: 6.32

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

As of today (2024-05-15), Kangji Medical Holdings's stock price is HK$7.64. Kangji Medical Holdings's Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2023 was HK$0.86. Therefore, Kangji Medical Holdings's PS Ratio for today is 8.84.


Kangji Medical Holdings EV-to-Revenue Historical Data

The historical data trend for Kangji Medical Holdings's EV-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Kangji Medical Holdings EV-to-Revenue Chart

Kangji Medical Holdings Annual Data
Trend Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
EV-to-Revenue
Get a 7-Day Free Trial - 25.63 7.34 8.15 5.86

Kangji Medical Holdings Semi-Annual Data
Dec17 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
EV-to-Revenue Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only 7.34 - 8.15 - 5.86

Competitive Comparison of Kangji Medical Holdings's EV-to-Revenue

For the Medical Instruments & Supplies subindustry, Kangji Medical Holdings's EV-to-Revenue, along with its competitors' market caps and EV-to-Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Kangji Medical Holdings's EV-to-Revenue Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Kangji Medical Holdings's EV-to-Revenue distribution charts can be found below:

* The bar in red indicates where Kangji Medical Holdings's EV-to-Revenue falls into.



Kangji Medical Holdings EV-to-Revenue Calculation

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

Kangji Medical Holdings's EV-to-Revenue for today is calculated as:

EV-to-Revenue=Enterprise Value (Today)/Revenue (TTM)
=6422.342/1012.865
=6.34

Kangji Medical Holdings's current Enterprise Value is HK$6,422 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Kangji Medical Holdings's Revenue for the trailing twelve months (TTM) ended in Dec. 2023 was HK$1,013 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Kangji Medical Holdings  (HKSE:09997) EV-to-Revenue Explanation

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

Kangji Medical Holdings's PS Ratiofor today is calculated as:

PS Ratio=Share Price (Today)/Revenue per Share (TTM)
=7.64/0.864
=8.84

Kangji Medical Holdings's share price for today is HK$7.64.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. {COMPANY->company}'s Revenue per Sharefor the trailing twelve months (TTM) ended in Dec. 2023 was HK$0.86.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Kangji Medical Holdings EV-to-Revenue Related Terms

Thank you for viewing the detailed overview of Kangji Medical Holdings's EV-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.


Kangji Medical Holdings (HKSE:09997) Business Description

Traded in Other Exchanges
Address
No. 1668 Chunjiang East Road, Tonglu Economic Development Zone, Zhejiang Province, Hangzhou, CHN
Kangji Medical Holdings Ltd is engaged in the production and sales of minimally invasive surgical instruments and accessories. The company offers a product portfolio to provide physicians and hospitals with one-shop and tailored surgical solutions for four surgical specialties OBGYN, general surgery, urology, and thoracic surgery. It manufactures and sells both disposable and reusable products. Its product portfolio includes disposable trocars, polymer ligation clips, disposable electrocoagulation forceps, and reusable trocar and forceps. It derives the majority of its revenue from Mainland China.

Kangji Medical Holdings (HKSE:09997) Headlines

No Headlines